| Ident. | Authors (with country if any) | Title |
|---|
| 000004 (2020) |
Georgeta Serban | Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections |
| 000010 (2020) |
Lisa M. Parsons [États-Unis] ; Yanming An [États-Unis] ; Li Qi [États-Unis] ; Mitchell R. White [États-Unis] ; Roosmarijn Van Der Woude [Pays-Bas] ; Kevan L. Hartshorn [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; Robert P. De Vries [Pays-Bas] ; John F. Cipollo | Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: N-Glycan Subtypes in Host-Pathogen Interactions. |
| 000013 (2020) |
Yafen Song [République populaire de Chine] ; Yong Zhang [République populaire de Chine] ; Bing Zhang [République populaire de Chine] ; Ling Chen [République populaire de Chine] ; Min Zhang [République populaire de Chine] ; Jingwen Wang [République populaire de Chine] ; Ying Jiang [République populaire de Chine] ; Chenghuai Yang [République populaire de Chine] ; Taozhen Jiang [République populaire de Chine] | Identification, Genetic Analysis, and Pathogenicity of Classical Swine H1N1 and Human-Swine Reassortant H1N1 Influenza Viruses from Pigs in China. |
| 000041 (2019) |
Pui Wang ; Wenjun Song [République populaire de Chine] ; Bobo Wing-Yee Mok ; Min Zheng ; Siu-Ying Lau ; Siwen Liu ; Pin Chen ; Xiaofeng Huang ; Honglian Liu ; Conor J. Cremin ; Honglin Chen | The PB2 Polymerase Host Adaptation Substitutions Prime Avian Indonesia Sub Clade 2.1 H5N1 Viruses for Infecting Humans |
| 000044 (2019) |
Wenjuan Du [Pays-Bas] ; Hongbo Guo [Pays-Bas] ; Vera S. Nijman [Pays-Bas] ; Jennifer Doedt [Allemagne] ; Erhard Van Der Vries [Pays-Bas] ; Joline Van Der Lee [Pays-Bas] ; Zeshi Li [Pays-Bas] ; Geert-Jan Boons [Pays-Bas] ; Frank J. M. Van Kuppeveld [Pays-Bas] ; Erik De Vries [Pays-Bas] ; Mikhail Matrosovich [Allemagne] ; Cornelis A. M. De Haan [Pays-Bas] | The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance |
| 000048 (2019) |
Irina Isakova-Sivak [Russie] ; Victoria Matyushenko [Russie] ; Tatiana Kotomina [Russie] ; Irina Kiseleva [Russie] ; Elena Krutikova [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Natalia Larionova [Russie] ; Daria Mezhenskaya [Russie] ; Konstantin Sivak [Russie] ; Arman Muzhikyan [Russie] ; Anastasia Katelnikova [Russie] ; Larisa Rudenko [Russie] | Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge |
| 000102 (2019) |
Laura Rodriguez ; Pilar Blanco-Lobo ; Emma C. Reilly [États-Unis] ; Tatsuya Maehigashi ; Aitor Nogales ; Andrew Smith [États-Unis] ; David J. Topham [États-Unis] ; Stephen Dewhurst ; Baek Kim [Corée du Sud] ; Luis Martínez-Sobrido | Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines |
| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000176 (2018) |
Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines |
| 000199 (2018) |
Ya-Fang Wang [Taïwan] ; Chuan-Fa Chang [Taïwan] ; Huey-Pin Tsai [Taïwan] ; Chia-Yu Chi [Taïwan] ; Ih-Jen Su [Taïwan] ; Jen-Ren Wang [Taïwan] | Glycan-binding preferences and genetic evolution of human seasonal influenza A(H3N2) viruses during 1999-2007 in Taiwan |
| 000207 (2018) |
Karolina Dzi Bowska [Pologne] ; El Bieta Czaczyk [Pologne] ; Dawid Nidzworski [Pologne] | Detection Methods of Human and Animal Influenza Virus—Current Trends |
| 000289 (2017) |
Christopher S. Anderson ; Sandra Ortega ; Francisco A. Chaves ; Amelia M. Clark ; Hongmei Yang [États-Unis] ; David J. Topham ; Marta L. Dediego | Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain |
| 000297 (2017) |
Andrey Rekstin [Russie] ; Irina Isakova-Sivak [Russie] ; Galina Petukhova [Russie] ; Daniil Korenkov [Russie] ; Igor Losev [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein |
| 000316 (2017) |
Ryuji Nakashima ; Masaomi Kawamoto ; Shigeru Miyazaki ; Rumiko Onishi ; Koichi Furusaki ; Maho Osaki ; Rikio Kirisawa ; Akikazu Sakudo ; Takashi Onodera | Evaluation of calcium hydrogen carbonate mesoscopic crystals as a disinfectant for influenza A viruses |
| 000318 (2017) |
Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis] | Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice |
| 000338 (2017) |
Tülin Morç L [États-Unis] ; Brett L. Hurst [États-Unis] ; E. Bart Tarbet [États-Unis] | Calcium Phosphate Nanoparticle (CaPNP) for Dose-Sparing of Inactivated Whole Virus Pandemic Influenza A (H1N1) 2009 Vaccine in Mice |
| 000392 (2016) |
Hung-Lun Hsu [États-Unis] ; Jean K. Millet [États-Unis] ; Deirdre A. Costello [États-Unis] ; Gary R. Whittaker [États-Unis] ; Susan Daniel [États-Unis] | Viral fusion efficacy of specific H3N2 influenza virus reassortant combinations at single-particle level |
| 000458 (2016) |
Irina Isakova-Sivak [Russie] ; Daniil Korenkov [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Li-Mei Chen [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model |
| 000470 (2016) |
Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie] | High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant |
| 000512 (2015) |
S. K. Rosendahl Huber [Pays-Bas] ; M. G. M. Camps [Pays-Bas] ; R. H. J. Jacobi [Pays-Bas] ; J. Mouthaan [Pays-Bas] ; H. Van Dijken [Pays-Bas] ; J. Van Beek [Pays-Bas] ; F. Ossendorp [Pays-Bas] ; J. De Jonge [Pays-Bas] | Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets |
| 000522 (2015) |
Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie] | Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers |
